Detalles de la búsqueda
1.
Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries.
Future Oncol
; 16(25): 1889-1901, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32515225
2.
Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom.
BMC Cancer
; 19(1): 91, 2019 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30665371
3.
Treatment patterns of prostate cancer with bone metastasis in Beijing: A real-world study using data from an administrative claims database.
Pharmacoepidemiol Drug Saf
; 28(11): 1501-1509, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31397051
4.
Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.
Oncotarget
; 15: 106-116, 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329731
5.
Predictive Models for Assessing Patients' Response to Treatment in Metastatic Prostate Cancer: A Systematic Review.
Eur Urol Open Sci
; 63: 126-135, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596781
6.
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Cancer Treat Res Commun
; 33: 100623, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041373
7.
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology.
Cancers (Basel)
; 14(20)2022 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291905
8.
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
Eur Urol Oncol
; 5(2): 153-163, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34785188
9.
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium.
Eur Urol
; 81(5): 503-514, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35184906
10.
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review.
BMJ Open
; 12(4): e058267, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379637
11.
TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting.
Target Oncol
; 16(3): 389-399, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33893941
12.
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol.
BMJ Open
; 11(2): e040531, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574142
13.
The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer.
Eur Urol Focus
; 7(5): 943-946, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34602368
14.
Overall survival and second primary malignancies in men with metastatic prostate cancer.
PLoS One
; 15(2): e0227552, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32084147
15.
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research.
Nat Rev Urol
; 17(8): 482, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32587405
16.
Introducing PIONEER: a project to harness big data in prostate cancer research.
Nat Rev Urol
; 17(6): 351-362, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32461687
17.
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States.
Prostate Cancer
; 2019: 4387415, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30886751
18.
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States".
Prostate Cancer
; 2019: 3425982, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355002
19.
Prostate cancer with bone metastasis in Beijing: an observational study of prevalence, hospital visits and treatment costs using data from an administrative claims database.
BMJ Open
; 9(6): e028214, 2019 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31230019
20.
Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.
Cancer Res
; 63(16): 4805-8, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12941799